Abstract

Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB), accounting for around 1-5% of the global TB caseload, with mortality of approximately 20% in children and up to 60% in persons co-infected with human immunodeficiency virus even in those treated. Relatively few centres of excellence in TBM research exist and the field would therefore benefit from greater co-ordination, advocacy, collaboration and early data sharing. To this end, in 2009, 2015 and 2019 we convened the TBM International Research Consortium, bringing together approximately 50 researchers from five continents. The most recent meeting took place on 1 st and 2 nd March 2019 in Lucknow, India. During the meeting, researchers and clinicians presented updates in their areas of expertise, and additionally presented on the knowledge gaps and research priorities in that field. Discussion during the meeting was followed by the development, by a core writing group, of a synthesis of knowledge gaps and research priorities within seven domains, namely epidemiology, pathogenesis, diagnosis, antimicrobial therapy, host-directed therapy, critical care and implementation science. These were circulated to the whole consortium for written input and feedback. Further cycles of discussion between the writing group took place to arrive at a consensus series of priorities. This article summarises the consensus reached by the consortium concerning the unmet needs and priorities for future research for this neglected and often fatal disease.

Highlights

  • Tuberculous meningitis (TBM) is caused when Mycobacterium tuberculosis enters the cerebrospinal fluid (CSF), leading to inflammation of the meninges, and subsequent clinical features of meningitis[1]

  • Our current understanding of the epidemiology, natural history and pathophysiology of TBM is limited and it will only be through an improved appreciation of these areas that appropriate clinical and public health interventions will be possible

  • In this article we describe the process of developing a TBM research agenda and outline the priorities that were developed

Read more

Summary

Introduction

Tuberculous meningitis (TBM) is caused when Mycobacterium tuberculosis enters the cerebrospinal fluid (CSF), leading to inflammation of the meninges, and subsequent clinical features of meningitis[1]. Identifying knowledge gaps and research priorities for TBM The 3rd TBM International Research Consortium took place in Lucknow on the 1st and 2nd March 2019. Cross-sectional studies/analysis of TB registers to identify what proportion of TB cohorts are TBM/which patients get TBM. Modelling studies to evaluate the number of deaths from TBM, given number of cases, the proportion diagnosed and expected mortality treated and untreated. Cohort studies of individuals who have been exposed to TB and followed to determine who progresses to TBM and evaluates risk factors for progression. Cohort studies of TBM patients with evaluation of baseline and follow up risk factors for mortality and morbidity. Cohort studies of TBM patients to identify risk factors for morbidity in survivors. How can we improve outcomes in HIV-infected patients, children, and individuals with drug-resistant TBM?

Study design
Conclusions
10. Lincoln EM
15. Rich AR
54. Donald PR
Findings
58. Begley DJ
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.